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Nuclear factor of activated T-cells 5 increases 
intestinal goblet cell differentiation through an 
mTOR/Notch signaling pathway
Yuning Zhoua, Qingding Wanga,b, Heidi L. Weissa, and B. Mark Eversa,b
aMarkey Cancer Center and bDepartment of Surgery, University of Kentucky, Lexington, KY 40536
ABSTRACT The intestinal mucosa undergoes a continual process of proliferation, differentia-
tion, and apoptosis that is regulated by multiple signaling pathways. Previously, we have 
shown that the nuclear factor of activated T-cells 5 (NFAT5) is involved in the regulation of 
intestinal enterocyte differentiation. Here we show that treatment with sodium chloride 
(NaCl), which activates NFAT5 signaling, increased mTORC1 repressor regulated in develop-
ment and DNA damage response 1 (REDD1) protein expression and inhibited mTOR signal-
ing; these alterations were attenuated by knockdown of NFAT5. Knockdown of NFAT5 acti-
vated mammalian target of rapamycin (mTOR) signaling and significantly inhibited REDD1 
mRNA expression and protein expression. Consistently, overexpression of NFAT5 increased 
REDD1 expression. In addition, knockdown of REDD1 activated mTOR and Notch signaling, 
whereas treatment with mTOR inhibitor rapamycin repressed Notch signaling and increased 
the expression of the goblet cell differentiation marker mucin 2 (MUC2). Moreover, knock-
down of NFAT5 activated Notch signaling and decreased MUC2 expression, while overex-
pression of NFAT5 inhibited Notch signaling and increased MUC2 expression. Our results 
demonstrate a role for NFAT5 in the regulation of mTOR signaling in intestinal cells. Impor-
tantly, these data suggest that NFAT5 participates in the regulation of intestinal homeostasis 
via the suppression of mTORC1/Notch signaling pathway.
INTRODUCTION
The epithelium of the mammalian intestine undergoes a process of 
continual renewal, characterized by active proliferation of stem cells 
localized near the base of the crypts, progression of these cells up 
the crypt–villus axis with cessation of proliferation, and subsequent 
differentiation into one of the four primary cell types (i.e., entero-
cytes, goblet cells, Paneth cells, and enteroendocrine cells; Cheng 
and Leblond, 1974; Yeung et al., 2011). Over a 3- to 5-d period, the 
differentiated colonocytes and enterocytes are extruded into the 
intestinal lumen. Mucin 2 (MUC2), the predominant structural com-
ponent of the intestinal mucus layer, is exclusively and abundantly 
expressed by goblet cells in the colon (Tytgat et al., 1995; Garg 
et al., 2007). MUC2 is secreted into the lumen and forms the mucus 
layer, acting as a barrier between the luminal contents and the epi-
thelial surface to protect the epithelium from pathogens (Shirazi 
et al., 2000).
The mechanisms by which committed cells are allocated to the 
different cell lineages of the intestine are not entirely known.
The nuclear factor of activated T-cell (NFAT) family proteins are 
a family of transcription factors. Five NFAT family members 
(NFAT1–5) have been identified and shown to regulate cell differ-
entiation and development in a number of cell types (Santini et al., 
2001; Luo et al., 2006; Kao et al., 2009; Zhou et al., 2012). NFAT5 
has a large C-terminal region that harbors a hypertonicity-sensitive 
transactivation domain such that hyperosmotic stress can also acti-
vate NFAT5. Unlike NFAT1–4 proteins, the NFAT5 subcellular dis-
tribution and its phosphorylation state are not altered by calcineu-
rin (Lopez-Rodriguez et al., 1999, 2001). NFAT5 has been implicated 
in such diverse processes as embryonic development and cellular 
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(CHAC1; Mungrue et al., 2009) and G1 arrest and DNA damage 153 
(GADD153, also known as DDIT3; Fawcett et al., 1999; Mungrue 
et al., 2009). As REDD1 is an mTOR repressor, these results suggest 
that NFAT5 may inhibit mTOR signaling through the regulation of 
REDD1 expression in intestinal cells.
To better delineate the role of NFAT5 in REDD1 regulation, we 
transfected HT29 cells with nontargeting control (NTC) small inter-
fering RNA (siRNA) or siRNA targeting NFAT5. REDD1 mRNA ex-
pression was detected by real time reverse transcription PCR (RT-
PCR). As shown in Figure 1A, transfection of NFAT5 siRNA decreased 
REDD1 mRNA expression compared with cells transfected with NTC 
siRNA. The specificity and efficiency of knockdown of NFAT5 were 
confirmed by real-time RT-PCR as shown in Figure 1B. To address 
whether REDD1 mRNA repression paralleled the decrease in REDD1 
protein, we performed Western blotting (Figure 1C). Decreased 
REDD1 protein expression was noted with NFAT5 knockdown and, 
as a result of mTOR activation, NFAT5 knockdown increased the 
expression of the phosphorylated Ser-6 (p-Ser-6) compared with 
cells transfected with NTC siRNA. Consistently, decreased REDD1 
protein expression was also found in HT29 cells sta bly transfected 
with the short hairpin RNA (shRNA) targeting NFAT5 compared with 
that in the cells transfected with the control shRNA (Supplemental 
Figure S1). Therefore NFAT5 inhibition decreases REDD1 expres-
sion and activates mTOR signaling.
NFAT5 is an osmoregulator (Aramburu et al., 2006); treatment 
with sodium chloride (NaCl) increases NFAT5 protein expression in 
intestinal cells (Chen et al., 2011). For further confirmation that the 
role of NFAT5 in the regulation of REDD1, HT29 cells transfected 
with NTC siRNA or siRNA targeting NFAT5 were treated with 
100 mM NaCl to stimulate hypertonic shock. Whole-cell lysates 
were analyzed by Western blotting for detection of REDD1 protein 
expression (Figure 1D). Treatment with NaCl increased NFAT5 
expression. Furthermore, treatment with NaCl increased the expres-
sion of REDD1 and, as a result of mTOR inhibition, decreased phos-
phorylation of Ser-6; the increased REDD1 and decreased p-Ser-6 
expression were attenuated by knockdown of NFAT5. These results 
indicate that NFAT5 activation increases REDD1 expression and 
inhibits the mTORC1 signal pathway.
NFAT5 regulates REDD1 expression in HCT116, SW480, 
and Caco-2 cells
To determine whether NFAT5 regulates REDD1 expression in other 
intestinal cell lines, we transfected HCT116, SW480, and Caco-2 
cells with siRNA targeting NFAT5. Knockdown of NFAT5 decreased 
REDD1 protein expression and increased p-Ser-6 in these cell lines 
(Figure 2A). For further confirmation of NFAT5-mediated REDD1 in-
duction, HCT116 and Caco-2 cells were transfected with empty vec-
tor or plasmid encoding Myc-tagged NFAT5. As shown in Figure 2B, 
overexpression of NFAT5 increased REDD1 protein expression in 
HCT116 and Caco-2 cells. These data indicate a role for NFAT5 in 
REDD1 induction in intestinal cells.
REDD1/mTOR/Notch pathway is involved in the regulation 
of goblet cell marker MUC2
Recently we showed that knockdown of mTORC1 repressor REDD1 
decreased the expression of the goblet cell differentiation marker 
MUC2 (Zhou et al., 2012). Notch signaling plays a critical role in the 
regulation of goblet cell differentiation. Inhibition of the Notch path-
way leads to an increase in MUC2 expression and the number of 
goblet cells (Vooijs et al., 2011; Yeung et al., 2011). To determine 
whether REDD1 regulates Notch signaling in intestinal cells, we first 
transfected HT29 cells with NTC siRNA or siRNA targeting REDD1 
migration and proliferation (Aramburu et al., 2006). Previously we 
have shown that 1) NFATc1 and NFATc4 regulate intestinal entero-
cyte differentiation through induction of phosphatase and tensin 
homologue deleted on chromosome ten (Wang et al., 2011); 
2) NFATc3 inhibits mTOR via induction of regulated in develop-
ment and DNA damage response 1 (REDD1) and participates in 
the regulation of goblet cell differentiation (Zhou et al., 2012); and 
3) NFAT5 represses canonical Wnt signaling via inhibition of β-
catenin acetylation and participates in regulating intestinal entero-
cyte differentiation (Wang et al., 2013). Together these results sug-
gest differential roles of NFAT in the regulation of intestinal cell 
differentiation.
mTOR is a member of the phosphatidylinositol 3-kinase (PI3K)-
related kinase family and regulates protein translation, cell cycle 
progression, and cell proliferation (Gingras et al., 2001). The TOR 
signaling events are essential for epithelial growth, morphogenesis, 
and differentiation in the vertebrate intestine (Makky et al., 2007). 
mTOR exists in two complexes: mTORC1 (containing mTOR, Rap-
tor, etc.) and mTORC2 (containing mTOR, Rictor, etc.). The bacteri-
ally derived drug rapamycin allosterically inhibits mTOR activity 
(Guertin and Sabatini, 2007). mTORC1 is partially sensitive to ra-
pamycin treatment, whereas mTORC2 is believed to be rapamycin 
insensitive (Guertin and Sabatini, 2007). The REDD1 (RTP801/Dig2/
DDIT4) protein recently was found to be a negative regulator of 
mTORC1 signaling (Corradetti et al., 2005). It has been proposed 
that REDD1 inhibits mTORC1 by displacing tuberous sclerosis com-
plex 2 (tuberin or TSC2) from the 14-3-3 binding protein, allowing 
TSC2 to inhibit mTORC1 (DeYoung et al., 2008). Consequently loss 
of REDD1 in this setting induces further mTORC1 activation that 
drives tumorigenesis (DeYoung et al., 2008).
The Notch pathway plays a critical role in intestinal cell differentia-
tion (Vooijs et al., 2011). Ligand engagement causes the Notch intra-
cellular domain (NICD) to be cleaved from the membrane and shut-
tled to the nucleus, where it forms and establishes a transcriptional 
activator complex leading to the expression of Notch target genes 
such as Hes1. Inhibition of the Notch/Hes1 pathway leads to an in-
crease in the expression of MUC2, a goblet cell differentiation marker, 
and the number of goblet cells (Vooijs et al., 2011). We have reported 
that the REDD1/TSC2 axis plays a role in the regulation of MUC2 
expression in intestinal cells (Zhou et al., 2012). However, whether 
mTOR regulates MUC2 expression and the potential functional inter-
action of mTORC1 and Notch in intestinal cells is not known.
Previously we showed that NFAT5 represses canonical Wnt sig-
naling and participates in regulating intestinal cell differentiation. 
In our current study, we found that NFAT5 inhibits mTOR signaling 
through regulation of REDD1 expression. In addition, we showed 
that mTORC1 is a positive regulator of Notch signaling in intestinal 
cells. Moreover, we found that NFAT5 inhibits mTORC1 and con-
tributes to the induction of MUC2 expression. Our study demon-
strates the regulation of mTORC1 signaling by NFAT5 and a novel 
role of mTORC1 signaling in the regulation of intestinal cell 
differentiation.
RESULTS
NFAT5 activation increases REDD1 expression in HT29 cells
Previously we showed that NFAT5 contributes to intestinal entero-
cyte differentiation (Wang et al., 2013). In an effort to better delin-
eate the mechanism underlying the effect of NFAT5 in intestinal 
cells, we performed a whole-genome expression array (Supplemen-
tal Table S1). Knockdown of NFAT5 in HT29 cells resulted in a signifi-
cant decrease of ATF4 target genes, including REDD1 (also known 
as DDIT4; Jin et al., 2011), cation transport regulator-like protein 1 
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cells with rapamycin. As shown in Figure 3B, treatment with rapamy-
cin decreased the Notch transactivator NCID domain and Hes1 ex-
pression, suggesting mTOR-positive regulation of Notch signaling.
(Figure 3A). Knockdown of REDD1 increased the Notch transactiva-
tor NICD domain and Hes1 expression, suggesting REDD1 negative 
regulation of Notch signaling in HT29 cells. We next treated HT29 
FIGURE 1: NFAT5 regulates REDD1 expression in HT29 cells. (A and B) HT29 cells were transfected with NFAT5 or NTC 
siRNA. After 48-h incubation, transfected cells were lysed, total RNA was extracted, and real-time RT PCR was 
performed for analysis of REDD1 (A) and NFAT5 and NFATc1, NFATc2, NFATc3, and NFATc4 mRNA expression (B). (Data 
represent mean ± SD; *, p < 0.01 vs. NTC siRNA as determined by ANOVA.) (C) HT29 cells were transfected with 
NFAT5 or NTC siRNA. After 48-h incubation, transfected cells were lysed, and Western blot analysis was performed 
using antibodies against REDD1, p-Ser-6, Ser-6, NFAT5, and β-actin. (D) HT29 cells were transfected with NFAT5 or NTC 
siRNA. After 24-h incubation, transfected cells were treated with 100 mM NaCl for an additional 24 h and subjected to 
Western blot analysis using antibodies against NFAT5, REDD1, p-Ser-6, total Ser-6, and β-actin. REDD1 signals from 
three separate experiments were quantitated densitometrically and expressed as fold change with respect to β-actin.
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enhances intestinal enterocyte differentiation (Wang et al., 2001). In 
this study, we found that decreased mTOR activity was associated 
with enterocyte differentiation (Figures S2 and S3). For testing 
whether mTORC1 regulates goblet cell differentiation, HT29 cells 
were treated with rapamycin (100 nM) for 24 h and MUC2 mRNA 
Previously we showed that knockdown of REDD1 or TSC2 acti-
vates mTOR and significantly decreases MUC2 expression (Zhou 
et al., 2012), suggesting a role for mTOR in the regulation of intesti-
nal goblet cell differentiation. In addition, we have shown that inhibi-
tion of PI3K/Akt, an upstream and downstream regulator of mTOR, 
FIGURE 2: NFAT5 regulates REDD1 expression in HCT116, SW480 and Caco-2 cells. (A) HCT116, SW480, and Caco-2 
cells were transfected with NFAT5 or NTC siRNA. After 48-h incubation, transfected cells were lysed, and Western blot 
analysis was performed using antibodies against REDD1, p-Ser-6, Ser-6, NFAT5, and β-actin. (B) HCT116 and Caco-2 
cells were transiently transfected with empty vector or a construct expressing Myc-NFAT5. Forty-eight hours after 
transfection, cells were lysed, and Western blot analysis was performed using antibodies against REDD1, Myc-tag, and 
β-actin. REDD1 signals from three separate experiments were quantitated densitometrically and expressed as fold 
change with respect to β-actin.
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Zhou et al., 2012). HT29 and Caco-2 cell 
lines have been extensively used as in vitro 
models for delineating potential pathways 
leading to differentiation (Wang et al., 2001; 
Garg et al., 2007; Gobbi et al., 2012; Sodhi 
et al., 2012). To determine whether NFAT5 
regulates goblet cell differentiation, we used 
RNA from HT29 and Caco-2 cells trans-
fected with NTC siRNA or NFAT5 siRNA for 
analysis of MUC2 mRNA expression by real 
time RT-PCR. Knockdown of NFAT5 signifi-
cantly decreased MUC2 mRNA expression 
in HT29 and Caco-2 cells (Figure 5A). For 
further confirmation of the regulation of 
MUC2 by NFAT5, HCT116 and Caco-2 cells 
were transfected with empty vector or plas-
mid encoding Myc-tagged NFAT5. As 
shown in Figure 5B, overexpression of 
NFAT5 increased MUC2 mRNA expression 
in HCT116 and Caco-2 cells. These data in-
dicate a role for NFAT5 in MUC2 induction 
in intestinal cells. Taken together, our results 
demonstrate the regulation of intestinal 
goblet cell differentiation by the NFAT5/
mTORC1/Notch axis.
DISCUSSION
We have shown that induction of REDD1 ex-
pression enhances, whereas knockdown of 
REDD1 attenuates, goblet cell differentia-
tion in the HT29 cell line (Zhou et al., 2012). 
In our present study, we demonstrate by 
complementary approaches (i.e., siRNA 
knockdown and overexpression) that NFAT5 
regulates REDD1 expression and inhibits 
mTOR signaling. In addition, mTOR acti-
vates but NFAT5 inhibits Notch signaling. 
Concomitantly the inhibition of mTOR or overexpression of NFAT5 
increases the expression of MUC2, a marker of goblet cell differen-
tiation, but knockdown of NFAT5 decreases MUC2 expression. 
Taken together, our results suggest that intestinal goblet cell differ-
entiation is regulated by NFAT5/REDD1/mTOR signaling.
NFAT5 has been implicated in the signaling pathways regulating 
cell differentiation of various cell types (O’Connor et al., 2007; 
Berga-Bolanos et al., 2010). Our previous results showed that 
NFAT5 inhibits β-catenin signaling and participates in the regulation 
of intestinal enterocyte differentiation (Wang et al., 2013). In this 
study, we showed that NFAT5 increases REDD1 expression, inhibits 
mTOR-dependent Notch signaling, and contributes to MUC2 ex-
pression in intestinal cells. Wnt and Notch signaling pathways play 
important roles in maintaining and regulating intestinal homeostasis 
(Yeung et al., 2011). As intestinal cells reach the mid-crypt region, 
Notch and β-catenin/TCF activity is down-regulated, resulting in 
cell cycle arrest and differentiation (van de Wetering et al., 2002; 
Yeung et al., 2011). The fact that NFAT5 antagonizes Wnt and Notch 
signaling is in agreement with the expression patterns of these 
genes. The expression pattern of NFAT5 in the more differentiated 
portions of the intestinal mucosa (Wang et al., 2013) suggest that 
the balance between NFAT5/REDD1 and Wnt or Notch signaling 
plays an important role in the maintenance of intestinal homeostasis 
at the crypt–villus axis in intestine. We showed that knockdown 
of NFAT5 decreased the expression of REDD1. Moreover, REDD1 
levels were analyzed by real time RT-PCR. Consistent with knock-
down of REDD1 or TSC2 (Zhou et al., 2012), treatment with rapamy-
cin increased MUC2 mRNA expression in HT29 cells (Figure 3C). 
Taken together, our results demonstrate the regulation of intestinal 
goblet cell differentiation by mTORC1/Notch signaling.
NFAT5 inhibits Notch signaling and increases MUC2 
expression in intestinal cells
We have shown that NFAT5 inhibits mTORC1 through the regula-
tion of REDD1 expression. In addition, we found that inhibition of 
mTORC1 inhibits Notch signaling. We next determined whether 
NFAT5 regulates Notch signaling. HT29 and HCT116 cells were 
transfected with NTC siRNA or siRNA targeting NFAT5, and the ex-
pression of NICD and Hes1 was determined (Figure 4A). Knock-
down of NFAT5 increased the protein expression of NICD and Hes1. 
For further confirmation of the regulation of Notch by NFAT5, 
Caco-2 cells were transfected with Myc-tagged NFAT5, and the 
expression of NICD and Hes1 was detected by Western blotting. As 
shown in Figure 4B, overexpression of NFAT5 decreased NICD and 
Hes1 protein expression in Caco-2 cells, suggesting the negative 
regulation of Notch by NFAT5 in intestinal cells.
Our results demonstrated the regulation of mTORC1 by NFAT5. 
In addition, we showed a role for mTORC1/Notch signaling in the 
regulation of goblet cell differentiation. MUC2 is expressed in HT29, 
Caco-2, and HCT116 cells (Barros et al., 2011; Mak et al., 2012; 
FIGURE 3: Regulation of MUC2 mRNA expression by mTORC1/Notch signaling pathway. 
(A) HT29 cells were transfected with NTC siRNA or siRNA targeting REDD1. (B) HT29 cells were 
treated with 100 nM rapamycin for 24 h. Total protein was extracted, and Western blotting was 
performed using anti-NICD, REDD1, anti–p-Ser-6, anti-Ser-6, Hes1, and anti–β-actin antibodies. 
NICD and Hes1 signals from three separate experiments were quantitated densitometrically and 
expressed as fold change with respect to β-actin. (C) HT29 cells were treated with 100 nM 
rapamycin for 24 h; total RNA was extracted and MUC2 mRNA levels were determined by 
real-time RT-PCR. (Data represent mean ± SD; *, p < 0.05 vs. control as determined by ANOVA.)
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Our results demonstrate the regulation of intestinal goblet cell 
differentiation by NFAT5/REDD1/mTOR/Notch signaling pathway. 
Notch signaling is required for formation and self-renewal of tumor-
initiating cells and for repression of secretory cell differentiation in 
colon cancer (Sikandar et al., 2010). Inhibition of Notch activation 
using pharmacological approaches or genetic manipulation results 
in the predominance of the goblet cell lineage in the intestine and 
colon (van Es et al., 2005). mTOR promotes Notch activation in cer-
tain types of cells (Ma et al., 2010; Pear, 2010; Francipane and 
Lagasse, 2013; Li et al., 2014), although rigorous proof was lacking 
that mTOR regulates Notch-1 activation in intestinal cells. In the 
present study, we show that the decreased mTORC1 activity is as-
sociated with increased intestinal cell differentiation. Signal trans-
ducer and activator of transcription 3 (STST3) has been identified as 
a downstream molecule of mTORC1 (Kim et al., 2009) and acts as a 
mediator between mTORC1 and Notch signaling pathways (Ma 
et al., 2010; Li et al., 2014). In addition, our previous results showed 
that the progressive decrease of STAT3 protein level and binding 
activity occurs at a time associated with increased Caco-2 cell dif-
ferentiation (Wang and Evers, 1999). However, loss of STAT3 does 
not affect intestinal cell differentiation (Mair et al., 2010). STAT3 
signaling may not be involved in mTOR-mediated regulation of 
inhibits Wnt/TCF activity (Feng et al., 2012). Therefore these find-
ings suggest that NFAT5 positively regulates the expression of 
REDD1 and thus contributes to its inhibitory role not only on mTOR 
but also on Wnt signaling in intestinal cells.
Although NFAT5 inhibits mTOR and Notch signaling and also 
contributes to MUC2 expression, NFAT5 may also regulate goblet 
cell differentiation through Wnt signaling. We showed that NFAT5 
negatively regulates Wnt signaling in intestinal cells (Wang et al., 
2013). NFAT proteins repress canonical Wnt signaling via their inter-
action with dishevelled protein and participate in regulating neural 
progenitor cell proliferation and differentiation (Huang et al., 2011). 
In the intestine, the Wnt signaling pathway has been implicated in 
regulating the balance between proliferation and differentiation 
(van de Wetering et al., 2002). Wnt signaling controls the differentia-
tion of the secretory cell lineage of the epithelium (Yeung et al., 
2011). High Wnt activity interferes with goblet cell differentiation 
(Sansom et al., 2004), and inhibition of Wnt signaling favors the 
goblet cell phenotype (Yeung et al., 2011; Heuberger et al., 2014). 
Moreover, Wnt stimulates cell growth by activating the TSC-mTOR 
pathway (Inoki et al., 2006). Taken together, these results have 
shown that multisignaling pathways are integrated and contribute 
to the maintenance of intestinal cell homeostasis.
FIGURE 4: NFAT5 inhibits Notch signaling. (A) HT29 or HCT116 cells were transfected with NTC siRNA or siRNA 
targeting NFAT5. (B) Caco-2 cells were transfected with control vector or NFAT5 plasmid. After 48-h incubation, total 
protein was extracted and subjected to Western blotting using anti-NICD, anti–p-Ser-6, anti-Ser-6, Hes1, and anti–β-
actin antibodies. NICD and Hes1 signals from three separate experiments were quantitated densitometrically and 
expressed as fold change with respect to β-actin.
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goblet cell differentiation. Although the di-
rect link between the intestinal inflamma-
tory process and NFAT5 activation is not 
known, patients with IBD present with in-
creased luminal hyperosmolality, which 
may result in NFAT5 activation in intestinal 
epithelial cells (Neuhofer, 2010). In addi-
tion, we have shown that NFAT5 is abun-
dantly expressed in intestinal epithelial 
cells (Wang et al., 2013). Therefore, since 
results in our current study show that NFAT5 
contributes to goblet cell differentiation, 
and NFAT5 has previously been shown to 
protect cells from osmotic stress (Lopez-
Rodriguez et al., 2004; Aramburu et al., 
2006), it is possible that a feedback activa-
tion of NFAT5 may play a defensive role in 
the process of IBD. The use of conditional 
NFAT5 knockout mice will be helpful to 
better delineate this process. Nevertheless, 
we now identify a novel role for NFAT5 in 
intestinal epithelial differentiation, suggest-
ing that further exploration of the NFAT5/
mTOR/Notch signaling pathway may offer 
novel therapeutic approaches to UC and 
NEC.
In conclusion, our results demonstrate 
that NFAT5 contributes to the regulation 
of the mTOR repressor REDD1 and thus 
inhibits mTORC1. Furthermore, our study 
demonstrates a positive regulation of 
Notch by mTORC1 and a novel role for the NFAT5/mTORC1/
Notch axis in the regulation of goblet cell differentiation (summa-
rized in Figure 6). In the normal intestine, Notch signaling regu-
lates cell proliferation in the base of crypts and inhibits goblet dif-
ferentiation in the upper portion of crypts. NFAT5 is expressed 
mainly in differentiated epithelial cells. Our findings suggest that 
NFAT5 plays a critical role in the regulation of intestinal homeosta-
sis through negative regulation of Wnt and mTORC1-dependent 
Notch signaling.
MATERIALS AND METHODS
Materials
Sodium butyrate and antibody against β-actin were purchased 
from Sigma-Aldrich (St. Louis, MO). Rabbit polyclonal anti-NFAT5 
antibody was from Thermo Fisher Scientific (Rockford, IL). Rabbit 
polyclonal anti-REDD1 antibody was purchased from Proteintech 
Group (Chicago, IL). Rabbit monoclonal anti-Notch1 (NICD) anti-
body was from Epitomics (Burlingame, CA). Rabbit anti-Hes1 
antibody was from Abcam (Cambridge, MA). Rapamycin and 
antibodies against phospho-mTOR (Ser-2448), mTOR, p-Ser-6 
(pS235/236), and Ser-6 antibodies were purchased from Cell Sig-
naling (Beverly, MA). The plasmid encoding human Myc-tagged 
NFAT5 was from Alex Toker (Boston, MA). Human NFAT5, REDD1, 
and NTC siRNA SMARTpool were purchased from Dharmacon 
(Lafayette, CO). siRNA SMARTpool, consisting of four siRNA du-
plexes, was designed using an algorithm made up of 33 criteria 
and parameters that effectively eliminate nonfunctional siRNA 
(Reynolds et al., 2004). Non-targeting Control Pool (D-001810-
10-50) is designed and microarray tested for minimal targeting of 
human, mouse, or rat genes, according to the manufacturer’s 
description.
goblet cell differentiation. How mTORC1 regulates Notch signaling 
and goblet cell differentiation remains to be defined.
Mucins, secreted by goblet cells, form a semipermeable mucous 
layer between the lumen and the intestinal epithelium, thus protect-
ing the epithelial surface of the gastrointestinal tract (Shirazi et al., 
2000; Einerhand et al., 2002). Abnormal regulation of goblet cell 
differentiation has been shown to be associated with the pathoge-
netic mechanisms leading to ulcerative colitis (UC), one type of in-
flammatory bowel disease (IBD), and necrotizing enterocolitis (NEC). 
In UC, the mucus layer, which protects the host from the enormous 
amount of luminal microbes, is defective (Gersemann et al., 2012). 
This is accompanied by an insufficient differentiation of goblet cells 
arising from the intestinal stem cells. Defects in this intestinal shield 
enable the luminal microorganisms to attack the epithelium. The 
number of MUC2-positive goblet cells is significantly decreased in 
neonatal rats with NEC (Clark et al., 2006). Consistently, Notch activ-
ity is increased in intestinal tissues of patients with NEC, and Notch 
activation is required for the induction of NEC in mice (Sodhi et al., 
2012; Lu et al., 2014). Inhibition of Notch signaling leads to in-
creased goblet cells and reduced severity of experimental NEC 
(Sodhi et al., 2012).
Abnormal activation of mTOR signaling is also consistently ob-
served in the colonic epithelial cells of human IBD patients with 
active disease (Deng et al., 2010). Inhibitors of TORC1 (rapamycin 
and rapalogs) have proven to be effective in IBD (Garcia-Maurino 
et al., 2012). Moreover, gut ischemia has been implicated in the 
pathogenesis of NEC. Treatment with rapamycin significantly at-
tenuated ischemia/reperfusion injury in the gut (Puglisi et al., 
1996). Our results show that rapamycin inhibits Notch, suggesting 
that the potential role of rapamycin in the treatment of UC and 
NEC may be through the inhibition of Notch and the increase of 
FIGURE 5: NFAT5 regulation of MUC2 mRNA expression. (A) HT29 and Caco-2 cells were 
transfected with NTC siRNA or siRNA targeting NFAT5. (B) HCT116 and Caco-2 cells were 
transfected with control vector or NFAT5 plasmid. After 48-h incubation, total RNA was 
extracted, and MUC2 mRNA levels were determined by real-time RT-PCR. (Data represent mean 
± SD; *, p < 0.01 vs. control siRNA as determined by ANOVA.)
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Quantitative real time RT-PCR analysis was performed with an 
Applied Biosystems Prism 7000HT Sequence Detection System 
using TaqMan universal PCR master mix as we have described 
previously (Kim et al., 2004).
Statistical analysis
Comparisons of real time quantitative reverse transcription PCR 
(qRT-PCR) were performed between control siRNA versus NFAT5 
siRNA and control vector versus Myc-NFAT5, or across rapamycin 
treatment groups using a two-sample t test or analysis of variance 
(ANOVA) with pairwise comparisons using a contrast statement. Bar 
graphs represent mean ± SD levels in each group. p values < 0.05 
were considered statistically significant.
Cell culture, transfection, and treatment
The human colon cancer cell lines HT29 and HCT116 were main-
tained in McCoy’s 5A supplemented with 10% fetal calf serum (FCS). 
SW480 and Caco-2 were maintained in DMEM supplemented with 
10% FCS and MEM supplemented with 15% FCS, respectively. Cells 
were transfected with the siRNA duplexes and plasmids by elec-
troporation (Gene Pulser; Bio-Rad, Hercules, CA) and lipofectamine 
2000 (Invitrogen, CA), respectively, as we have described previously 
(Wang et al., 2003, 2006).
Western blot analysis
Total protein was resolved on a 10% polyacrylamide gel and trans-
ferred to polyvinylidene fluoride membranes. Membranes were in-
cubated for 1 h at room temperature in blotting solution. REDD1, 
NFAT5, NICD, Hes1, phospho-mTOR, mTOR, p-Ser-6, Ser-6, and β-
actin were detected with specific antibodies following blotting with 
a horseradish peroxidase–conjugated secondary antibody and visu-
alized using an enhanced chemiluminescence detection system.
Quantitative real time RT-PCR analysis
Total RNA was extracted and DNase treated (RQ1; Promega, 
Madison, WI). Synthesis of cDNA was performed with 1 μg of total 
RNA using reagents in the Taqman Reverse Transcription Reagents 
Kit (ABI N8080234). TaqMan probe and primers for human NFATc1, 
NFATc2, NFATc3, NFATc4, NFAT5, REDD1, MUC2, and GAPDH 
were purchased from Applied Biosystems (Foster City, CA). 
FIGURE 6: NFAT5/REDD1/mTOR/Notch pathway model. REDD1 is 
proposed to inhibit mTORC1 by displacing TSC2 from the 14-3-3 
binding protein, allowing TSC2 to inhibit mTORC1. Activation of 
NFAT5 increases REDD1 expression resulting in inhibition of mTORC1 
signaling, leading to decreased Notch signaling and an increase of 
goblet cell differentiation.
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